Newsletters and Deep Dive digital magazine
Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.
Dr Fiona Marshall joins MSD from Sosei from Heptares, the UK biotech company she co-founded more than a decade ago, and which was acquired by Sosei in 2015.
Richard Henderson, an influential figure in UK biotech research, has won the Nobel Prize for Chemistry for his work allowing scientists to see the three-dimensional structure of proteins fo
Phase 1 study of immuno-oncology drug candidate begins.
Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
An inside guide to unlocking clinical research in the UK